78 related articles for article (PubMed ID: 9831038)
1. DNA-based selection and screening of peptide ligands.
Bartoli F; Nuzzo M; Urbanelli L; Bellintani F; Prezzi C; Cortese R; Monaci P
Nat Biotechnol; 1998 Nov; 16(11):1068-73. PubMed ID: 9831038
[TBL] [Abstract][Full Text] [Related]
2. Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients.
Prezzi C; Nuzzo M; Meola A; Delmastro P; Galfrè G; Cortese R; Nicosia A; Monaci P
J Immunol; 1996 Jun; 156(11):4504-13. PubMed ID: 8666827
[TBL] [Abstract][Full Text] [Related]
3. Broadly cross-reactive mimotope of hypervariable region 1 of hepatitis C virus derived from DNA shuffling and screened by phage display library.
Zhang XX; Deng Q; Zhang SY; Liu J; Cai Q; Lu ZM; Wang Y
J Med Virol; 2003 Dec; 71(4):511-7. PubMed ID: 14556263
[TBL] [Abstract][Full Text] [Related]
4. "Affinity maturation" of ligands for HCV-specific serum antibodies.
Urbanelli L; Fortugno P; Bartoli F; Nuzzo M; De Tomassi A; Felici F; Monaci P
J Immunol Methods; 2000 Mar; 236(1-2):167-76. PubMed ID: 10699588
[TBL] [Abstract][Full Text] [Related]
5. Identification of a human epitope in hepatitis C virus (HCV) core protein using a molecularly cloned antibody repertoire from a non-symptomatic, anti-HCV-positive patient.
Barban V; Fraysse-Corgier S; Paranhos-Baccala G; Petit M; Manin C; Berard Y; Prince AM; Mandrand B; Meulien P
J Gen Virol; 2000 Feb; 81(Pt 2):461-9. PubMed ID: 10644845
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C epitopes from phage-displayed cDNA libraries and improved diagnosis with a chimeric antigen.
Pereboeva LA; Pereboev AV; Wang LF; Morris GE
J Med Virol; 2000 Feb; 60(2):144-51. PubMed ID: 10596013
[TBL] [Abstract][Full Text] [Related]
7. Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies.
Muerhoff AS; Gutierrez R; Kyrk C; Leary T; Schlauder G; Dawson G; Desai SM
J Med Virol; 2008 Mar; 80(3):411-8. PubMed ID: 18205228
[TBL] [Abstract][Full Text] [Related]
8. [Identification of HCV antigen epitopes from a random 15-peptide library by anti-HCV polycloral antibody].
Ke S; Zhu JP; Wen XY; Zhao P; Shi M; He YH; Yao ZJ; Shen BF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):65-7. PubMed ID: 15132911
[TBL] [Abstract][Full Text] [Related]
9. Selection of a phage-displayed peptide recognized by monoclonal antibody directed blocking the site of hepatitis C virus E2 for human CD81.
Cao J; Liao XL; Wu SM; Zhao P; Zhao LJ; Wu WB; Qi ZT
J Microbiol Methods; 2007 Mar; 68(3):601-4. PubMed ID: 17178166
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of the phage display technology for the identification of a hepatitis C virus NS4A epitope recognized early in the course of the disease.
Ferrieu-Weisbuch C; Bettsworth F; Becquart L; Paranhos-Baccala G; Michel S; Arnaud M; Jolivet-Reynaud C
J Virol Methods; 2006 Feb; 131(2):175-83. PubMed ID: 16183141
[TBL] [Abstract][Full Text] [Related]
11. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
[TBL] [Abstract][Full Text] [Related]
12. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
[TBL] [Abstract][Full Text] [Related]
13. [Screening and characterization of human phage antibody to hepatitis C core antigen].
Zhong Y; Cheng J; Shi S; Xia X; Wang G; Yang J; Chen J
Zhonghua Gan Zang Bing Za Zhi; 2001 Aug; 9(4):217-9. PubMed ID: 11602052
[TBL] [Abstract][Full Text] [Related]
14. Predominance of antibodies to hepatitis C virus envelope proteins in various disease statuses of hepatitis C.
PodurI CD; Khanna A; Khundmiri SJ; Khaja MN; Kumar KS; Sugunan VS; Habibullah CM; Das MR
Acta Virol; 2001 Feb; 45(1):1-6. PubMed ID: 11394572
[TBL] [Abstract][Full Text] [Related]
15. 'In vitro evolution' of ligands for HCV-specific serum antibodies.
Zhu ZY; Minenkova O; Bellintani F; De Tomassi A; Urbanelli L; Felici F; Monaci P
Biol Chem; 2000 Mar; 381(3):245-54. PubMed ID: 10782995
[TBL] [Abstract][Full Text] [Related]
16. Analysis of human immune response to potential hepatitis C viral epitopes.
Khanna A; Poduri CD; Murugan P; Kumar S; Sugunan VS; Shenoy KT; Das MR
Acta Virol; 1998 Jun; 42(3):141-5. PubMed ID: 9842443
[TBL] [Abstract][Full Text] [Related]
17. Identification of hepatitis A virus mimotopes by phage display, antigenicity and immunogenicity.
Larralde OG; Martinez R; Camacho F; Amin N; Aguilar A; Talavera A; Stott DI; Perez EM
J Virol Methods; 2007 Mar; 140(1-2):49-58. PubMed ID: 17129616
[TBL] [Abstract][Full Text] [Related]
18. Phage display selection on whole cells yields a small peptide specific for HCV receptor human CD81.
Cao J; Zhao P; Miao XH; Zhao LJ; Xue LJ; Qi Zt Zt
Cell Res; 2003 Dec; 13(6):473-9. PubMed ID: 14728804
[TBL] [Abstract][Full Text] [Related]
19. Artificial NS4 mosaic antigen of hepatitis C virus.
Chang JC; Ruedinger B; Cong M; Lambert S; Lopareva E; Purdy M; Holloway BP; Jue DL; Ofenloch B; Fields HA; Khudyakov YE
J Med Virol; 1999 Dec; 59(4):437-50. PubMed ID: 10534724
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of hepatitis C virus core antigen testing in pools among seroconverters.
Beer N; Shinar E; Novack L; Safi J; Soliman H; Yaari A; Goldman-Levi R; Yahalom V; Bolotin A; Sarov B
Transfusion; 2006 Oct; 46(10):1822-8. PubMed ID: 17002640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
